In the News

A thought leadership piece by Cindy Dukes exploring the unique challenges in planning and executing a seasonal vaccine study.

The traditional approaches to launching a new medicine still tend to sit in the commercial function, but they need to better align with HEOR, medical affairs and clinical teams.Read more in the February issue of PME.

ICON's Martin Lachs comments on the exponential growth of the cell and gene therapy market driven by the increasing prevalence of chronic diseases, launch of new products, regulatory support, and improved manufacturing expertise.

A thought leadership article by Dr. Nuala Murphy exploring how protocol optimisation can be instrumental in improving patient and site engagement to mobilise increasingly complex clinical trials.

An article by Gretchen Goller and Kristin Kinlaw which outlines patient feedback from a recent survey regarding the use of decentralized and hybrid trials in the pharmaceutical industry.

ICON's CIO Tom O'Leary provides expert commentary on integrating AI and machine learning into Pharma R&D in this January 2020 Bio IT World Article.

A thought leadership article authored by multiple contributors from ICON’s R&D department, which focuses on the future of Flow Cytometry as a sophisticated technology.

Skilled workforce and high-calibre research help Ireland compete internationally in Life sciences industry

ICON's Martin Benson provides expert commentary on liver disease in this December 2019 DDN News article.

A ‘review of the year’ thought leadership article, authored by Gretchen Goller, discussing the changing role of the patient throughout 2019.